As the end of Summer 2024 approaches and students prepare to return to school, the idea of getting a last-minute vaccination and heading to a warm beach sounds appealing.
However, with the global outbreak of dengue fever expanding in the Region of the Americas, it's crucial to choose a destination that is free from disease-carrying mosquitoes.
As of July 25, 2024, 43 countries and territories in the Region had reported over 10.8 million dengue cases and 5,848 related deaths.
Don't End Summer Vacation With Dengue
18.3 Percent of Physicians Reported PTSD During COVID-19 Pandemic
Increased likelihood seen for female physicians, older physicians, and trainees, and for emergency department doctors
$25 Million Boosts Clinical Trials Conducted at Pharmacies
When the U.S. government approves a vaccine, the clinical trial process does not stop. The fourth type of clinical evaluation is called Phase 4 or Post-Market Survalence.
These studies aggregate real-world evidence that hopefully meets or extends results reported in the pre-approval clinical trial.
Dog Importation Rules Clarified by the U.S. CDC
The U.S. Centers for Disease Control and Prevention (CDC) released a media statement with an updated process for bringing dogs into the United States from rabies-free and low-risk dog rabies countries to simplify and clarify the procedures.
Telehealth Only Partially Offset Decreased Primary Care Visits During Pandemic
Magnitude of these changes varied significantly by patient demographic characteristics
Long COVID Incidence Declined Over Course of Pandemic
However, authors say, risk remains substantial even among vaccinated persons during the omicron era
Social Distancing Measures Tied to Neonatal Mortality With Lag Period
With two-month lag period, social distancing index linked to higher neonatal and early neonatal mortality rates
$41.3 Million Supports Increased Access to the First Chikungunya Vaccine
As the most challenging disease to spell and pronounce continues its global expansion, access to the only approved chikungunya virus vaccine is becoming broader.
The Coalition for Epidemic Preparedness Innovations (CEPI) has expanded its support to provide expanded access to the world’s first chikungunya vaccine, IXCHIQ®.
IXCHIQ (VLA1553) is a monovalent, single-dose, live-attenuated chikungunya vaccine that the U.S. Food and Drug Administration approved in November 2023.
Two Mosquito-Transmitted Viruses Causing Microcephaly in Newborns
According to the Pan American Health Organization (PAHO), scientists in Brazil believe that the Oropouche virus (OROV) may cause stillbirths and neurological defects in babies who are infected in the womb, similar to the Zika virus.
Since 2013, 31 countries and territories in the Americas have reported cases of microcephaly (head shape issues) and other central nervous system malformations associated with Zika infection.
Fewer Mental Health Facilities Offering Telehealth Since End of Pandemic
Declines seen in scope and modality of services